140 related articles for article (PubMed ID: 17076271)
1. Splicing modulation as a modifier of the CFTR function.
Nissim-Rafinia M; Kerem B
Prog Mol Subcell Biol; 2006; 44():233-54. PubMed ID: 17076271
[TBL] [Abstract][Full Text] [Related]
2. Restoration of the cystic fibrosis transmembrane conductance regulator function by splicing modulation.
Nissim-Rafinia M; Aviram M; Randell SH; Shushi L; Ozeri E; Chiba-Falek O; Eidelman O; Pollard HB; Yankaskas JR; Kerem B
EMBO Rep; 2004 Nov; 5(11):1071-7. PubMed ID: 15472711
[TBL] [Abstract][Full Text] [Related]
3. Cellular and viral splicing factors can modify the splicing pattern of CFTR transcripts carrying splicing mutations.
Nissim-Rafinia M; Chiba-Falek O; Sharon G; Boss A; Kerem B
Hum Mol Genet; 2000 Jul; 9(12):1771-8. PubMed ID: 10915765
[TBL] [Abstract][Full Text] [Related]
4. Correction of a Cystic Fibrosis Splicing Mutation by Antisense Oligonucleotides.
Igreja S; Clarke LA; Botelho HM; Marques L; Amaral MD
Hum Mutat; 2016 Feb; 37(2):209-15. PubMed ID: 26553470
[TBL] [Abstract][Full Text] [Related]
5. The molecular basis of disease variability among cystic fibrosis patients carrying the 3849+10 kb C-->T mutation.
Chiba-Falek O; Kerem E; Shoshani T; Aviram M; Augarten A; Bentur L; Tal A; Tullis E; Rahat A; Kerem B
Genomics; 1998 Nov; 53(3):276-83. PubMed ID: 9799593
[TBL] [Abstract][Full Text] [Related]
6. Variable levels of normal RNA in different fetal organs carrying a cystic fibrosis transmembrane conductance regulator splicing mutation.
Chiba-Falek O; Parad RB; Kerem E; Kerem B
Am J Respir Crit Care Med; 1999 Jun; 159(6):1998-2002. PubMed ID: 10351951
[TBL] [Abstract][Full Text] [Related]
7. Assessing the residual CFTR gene expression in human nasal epithelium cells bearing CFTR splicing mutations causing cystic fibrosis.
Masvidal L; Igreja S; Ramos MD; Alvarez A; de Gracia J; Ramalho A; Amaral MD; Larriba S; Casals T
Eur J Hum Genet; 2014 Jun; 22(6):784-91. PubMed ID: 24129438
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological induction of CFTR function in patients with cystic fibrosis: mutation-specific therapy.
Kerem E
Pediatr Pulmonol; 2005 Sep; 40(3):183-96. PubMed ID: 15880796
[TBL] [Abstract][Full Text] [Related]
9. Antisense oligonucleotide splicing modulation as a novel Cystic Fibrosis therapeutic approach for the W1282X nonsense mutation.
Oren YS; Avizur-Barchad O; Ozeri-Galai E; Elgrabli R; Schirelman MR; Blinder T; Stampfer CD; Ordan M; Laselva O; Cohen-Cymberknoh M; Kerem E; Bear CE; Kerem B
J Cyst Fibros; 2022 Jul; 21(4):630-636. PubMed ID: 34972649
[TBL] [Abstract][Full Text] [Related]
10. The role of common single-nucleotide polymorphisms on exon 9 and exon 12 skipping in nonmutated CFTR alleles.
Steiner B; Truninger K; Sanz J; Schaller A; Gallati S
Hum Mutat; 2004 Aug; 24(2):120-9. PubMed ID: 15241793
[TBL] [Abstract][Full Text] [Related]
11. Expression of an abundant alternatively spliced form of the cystic fibrosis transmembrane conductance regulator (CFTR) gene is not associated with a cAMP-activated chloride conductance.
Strong TV; Wilkinson DJ; Mansoura MK; Devor DC; Henze K; Yang Y; Wilson JM; Cohn JA; Dawson DC; Frizzell RA
Hum Mol Genet; 1993 Mar; 2(3):225-30. PubMed ID: 7684641
[TBL] [Abstract][Full Text] [Related]
12. Five percent of normal cystic fibrosis transmembrane conductance regulator mRNA ameliorates the severity of pulmonary disease in cystic fibrosis.
Ramalho AS; Beck S; Meyer M; Penque D; Cutting GR; Amaral MD
Am J Respir Cell Mol Biol; 2002 Nov; 27(5):619-27. PubMed ID: 12397022
[TBL] [Abstract][Full Text] [Related]
13. Comparative ex vivo, in vitro and in silico analyses of a CFTR splicing mutation: Importance of functional studies to establish disease liability of mutations.
Ramalho AS; Clarke LA; Sousa M; Felicio V; Barreto C; Lopes C; Amaral MD
J Cyst Fibros; 2016 Jan; 15(1):21-33. PubMed ID: 25735457
[TBL] [Abstract][Full Text] [Related]
14. Correction of aberrant splicing of the cystic fibrosis transmembrane conductance regulator (CFTR) gene by antisense oligonucleotides.
Friedman KJ; Kole J; Cohn JA; Knowles MR; Silverman LM; Kole R
J Biol Chem; 1999 Dec; 274(51):36193-9. PubMed ID: 10593905
[TBL] [Abstract][Full Text] [Related]
15. Multi-physiopathological consequences of the c.1392G>T CFTR mutation revealed by clinical and cellular investigations.
Farhat R; El-Seedy A; El-Moussaoui K; Pasquet MC; Adolphe C; Bieth E; Languepin J; Sermet-Gaudelus I; Kitzis A; Ladevèze V
Biochem Cell Biol; 2015 Feb; 93(1):28-37. PubMed ID: 25403292
[TBL] [Abstract][Full Text] [Related]
16. Mutation specific therapy in CF.
Kerem E
Paediatr Respir Rev; 2006; 7 Suppl 1():S166-9. PubMed ID: 16798551
[TBL] [Abstract][Full Text] [Related]
17. A T3 allele in the CFTR gene exacerbates exon 9 skipping in vas deferens and epididymal cell lines and is associated with Congenital Bilateral Absence of Vas Deferens (CBAVD).
Disset A; Michot C; Harris A; Buratti E; Claustres M; Tuffery-Giraud S
Hum Mutat; 2005 Jan; 25(1):72-81. PubMed ID: 15580565
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneous spectrum of mutations in CFTR gene from Indian patients with congenital absence of the vas deferens and their association with cystic fibrosis genetic modifiers.
Sharma H; Mavuduru RS; Singh SK; Prasad R
Mol Hum Reprod; 2014 Sep; 20(9):827-35. PubMed ID: 24958810
[TBL] [Abstract][Full Text] [Related]
19. Cas9/gRNA targeted excision of cystic fibrosis-causing deep-intronic splicing mutations restores normal splicing of CFTR mRNA.
Sanz DJ; Hollywood JA; Scallan MF; Harrison PT
PLoS One; 2017; 12(9):e0184009. PubMed ID: 28863137
[TBL] [Abstract][Full Text] [Related]
20. Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing.
Liu X; Jiang Q; Mansfield SG; Puttaraju M; Zhang Y; Zhou W; Cohn JA; Garcia-Blanco MA; Mitchell LG; Engelhardt JF
Nat Biotechnol; 2002 Jan; 20(1):47-52. PubMed ID: 11753361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
